Oxford Biotrans Ltd, a spin-out of the University of Oxford, has received £2.5 million in a Series A funding round to commercialise an enzyme technology that has application to soft drinks and confectionary as well as to pharmaceuticals. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals